Announcements
Removal of Component(s) – ALXN
July 16, 2021
Effective at the market close on Tuesday, July 20, ALXN will be removed from the LifeSci Biotechnology Products Index and its value will be redistributed to the remaining index components based on their weights.
- On December 12, 2020, Alexion Pharmaceuticals, Inc. agreed to be acquired by AstraZeneca plc for $60.00 per share in cash and 2.1243 ADSs (American Depositary Shares) of AstraZeneca plc.
